Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Making tiny plastic particles to deliver lifesaving medicine

29.09.2003


Many medications such as therapeutic DNA, insulin and human growth hormone must enter the body through painful injections, but a Johns Hopkins researcher is seeking to deliver the same treatment without the sting. Justin Hanes wants to pack the drugs inside microscopic plastic spheres that can be inhaled painlessly. Inside the lungs, the particles should dissolve harmlessly, releasing the medicine at a predetermined pace.



"We’ve made significant progress," said Hanes, an assistant professor in the Whiting School of Engineering’s Department of Chemical and Biomolecular Engineering, "especially when you consider all of the challenges we’ve faced in designing and synthesizing these new biomaterials."

For one thing, the polymers used in making such particles must dissolve slowly in the body, releasing the medicine over a prescribed period of hours, days or even weeks. Also, these materials must be strong and flexible, so that the particles do not crack or crumble before delivering their treatment. At the same time, the particles must not stick together, forming clumps that will prevent proper travel through the air passages. Once the particles deposit in the lungs, some therapies will require that they cross the thick mucus lining of air passages prior to releasing their medicinal cargo. Finally, the materials must not trigger a strong immune response, in which the body’s natural defense system attacks a particle before it has delivered its dose.


Hanes and his lab colleagues have overcome many of these hurdles, publishing their research results in peer-reviewed journals. Last year, in an issue of "Biomaterials," Hanes’ team, including associate research scientist Jie Fu and doctoral candidate Jennifer Fiegel, reported that it had synthesized a new type of porous polymer particles capable of releasing drugs in an environment resembling the deep lungs. Importantly, the components used to create these plastic microspheres were materials already FDA-approved for other medical applications, making it more likely they will pose no health hazards to humans in their new polymeric form.

Recent work by Hanes, doctoral candidate Michelle Dawson and associate professor Denis Wirtz has focused on understanding how to alter the design of drug-carrying particles so that they can more efficiently cross the mucus lining in the lungs to reach their cell targets underneath. Reports on this work are expected appear shortly in the "Journal of Biology Chemistry," "Biotechnology Progress" and the "Journal of Aerosol Medicine."

Earlier this year, in "Proceedings of the National Academy of Sciences," Hanes, Wirtz and Junghae Suh, a doctoral candidate, reported that their nanoscopic particles appear to be able to efficiently deliver therapeutic genes by carrying DNA directly to the cell nucleus. Someday, Hanes said, this technique also may prove useful in delivering toxic cancer-fighting drugs only to cells affected by the disease.

For his research accomplishments, Hanes is being recognized in the October issue of MIT’s "Technology Review" as one of the world’s top 100 young innovators. The TR100, chosen by the publication’s editors and an elite panel of judges, consists of 100 individuals under 35 whose innovative work in technology has a profound impact on today’s world. Nominees are recognized for their contributions in transforming the nature of technology in industries such as biotechnology, computing, energy, medicine, manufacturing, nanotechnology, telecommunications and transportation. This marks the second consecutive year that a Johns Hopkins engineering faculty member has appeared on the TR100. Last year, the magazine singled out Jennifer Elisseeff, assistant professor of biomedical engineering, for her research in the field of tissue engineering.

Hanes has focused much of his attention on the lungs because they possess several advantages over other drug delivery routes. When medicine is swallowed, it must pass through the stomach, where it may be degraded by digestive acids. Injections may avoid this problem, but they also are painful and may be difficult for some patients to administer to themselves. Inhalation, however, as smokers and asthmatics know, is generally a quick and painless method of getting a drug into the body. Still, Hanes noted, "the lungs are pretty sacred ground. You have to be very conservative about what you put in there."

As a doctoral student at MIT, Hanes played a leading role in developing porous polymer drug delivery particles coated with a special surfactant native to the lung. The surfactant is designed to fool the body into thinking these particles belong in the lungs, warding off an immune response. In 1999, Hanes and his colleagues received a U.S. patent for this invention; Hanes currently holds eight U.S. patents for advanced drug delivery applications.

At Johns Hopkins, he is building upon this research by synthesizing improved inhalation particles, each about a tenth of the diameter of a human hair. He soon hopes to begin testing their safety and effectiveness in animal models and eventually in human trials. Hanes also is trying to produce even smaller particles that could be used to deliver powerful medications directly into diseased cells, while leaving normal tissue unharmed.

Hanes’ early research has been supported by several grants and awards, including one from the Whitaker Foundation.

Phil Sneiderman | EurekAlert!
Further information:
http://www.jhu.edu/
http://www.jhu.edu/~cheme/hanes/index.html
http://www.jhu.edu/chbe/index.asp

More articles from Health and Medicine:

nachricht Custom-tailored strategy against glioblastomas
26.09.2016 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht New leukemia treatment offers hope
23.09.2016 | King Abdullah University of Science and Technology

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First-Ever 3D Printed Excavator Project Advances Large-Scale Additive Manufacturing R&D

Heavy construction machinery is the focus of Oak Ridge National Laboratory’s latest advance in additive manufacturing research. With industry partners and university students, ORNL researchers are designing and producing the world’s first 3D printed excavator, a prototype that will leverage large-scale AM technologies and explore the feasibility of printing with metal alloys.

Increasing the size and speed of metal-based 3D printing techniques, using low-cost alloys like steel and aluminum, could create new industrial applications...

Im Focus: New welding process joins dissimilar sheets better

Friction stir welding is a still-young and thus often unfamiliar pressure welding process for joining flat components and semi-finished components made of light metals.
Scientists at the University of Stuttgart have now developed two new process variants that will considerably expand the areas of application for friction stir welding.
Technologie-Lizenz-Büro (TLB) GmbH supports the University of Stuttgart in patenting and marketing its innovations.

Friction stir welding is a still-young and thus often unfamiliar pressure welding process for joining flat components and semi-finished components made of...

Im Focus: First quantum photonic circuit with electrically driven light source

Optical quantum computers can revolutionize computer technology. A team of researchers led by scientists from Münster University and KIT now succeeded in putting a quantum optical experimental set-up onto a chip. In doing so, they have met one of the requirements for making it possible to use photonic circuits for optical quantum computers.

Optical quantum computers are what people are pinning their hopes on for tomorrow’s computer technology – whether for tap-proof data encryption, ultrafast...

Im Focus: OLED microdisplays in data glasses for improved human-machine interaction

The Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP has been developing various applications for OLED microdisplays based on organic semiconductors. By integrating the capabilities of an image sensor directly into the microdisplay, eye movements can be recorded by the smart glasses and utilized for guidance and control functions, as one example. The new design will be debuted at Augmented World Expo Europe (AWE) in Berlin at Booth B25, October 18th – 19th.

“Augmented-reality” and “wearables” have become terms we encounter almost daily. Both can make daily life a little simpler and provide valuable assistance for...

Im Focus: Artificial Intelligence Helps in the Discovery of New Materials

With the help of artificial intelligence, chemists from the University of Basel in Switzerland have computed the characteristics of about two million crystals made up of four chemical elements. The researchers were able to identify 90 previously unknown thermodynamically stable crystals that can be regarded as new materials. They report on their findings in the scientific journal Physical Review Letters.

Elpasolite is a glassy, transparent, shiny and soft mineral with a cubic crystal structure. First discovered in El Paso County (Colorado, USA), it can also be...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Paper – Panacea Green Infrastructure?

30.09.2016 | Event News

HLF: From an experiment to an establishment

29.09.2016 | Event News

European Health Forum Gastein 2016 kicks off today

28.09.2016 | Event News

 
Latest News

First-Ever 3D Printed Excavator Project Advances Large-Scale Additive Manufacturing R&D

30.09.2016 | Materials Sciences

New Technique for Finding Weakness in Earth’s Crust

30.09.2016 | Earth Sciences

Cells migrate collectively by intermittent bursts of activity

30.09.2016 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>